Stress-Related Disorders Linked to Neurodegenerative Disease
Risk increase greater for vascular neurodegenerative disease than for primary neurodegenerative disease.
Alzheimer Disease and Dementia
Alzheimer Disease Gene Mapping Project Proposed in New York State
Governor says initiative will help researchers working to slow the progression of Alzheimer disease.
Antipsychotic Initiation Ups Risk for Head Injury, TBI in Alzheimer Disease
TBI injury risk up for quetiapine vs risperidone users.
Review Identifies Current Diagnostic Methods, Pharmacologic, Nonpharmacologic Approaches to Dementia
Medical history, cognitive and physical examination, laboratory testing, and brain imaging can help identify causes of dementia, and several pharmacologic and nonpharmacologic approaches can help manage the disease.
More Hospital Days Seen With Antipsychotic Use in Alzheimer Disease
Number of hospital days up by more than 50% in AD patients initiating antipsychotic medication.
New Alzheimer Disease Drug to Be Submitted for FDA Approval
New analysis of study results suggests highest dose of aducanumab may help slow cognitive decline.
Neurologic Impairment May Persist in HIV Encephalopathy Despite Potent ART
Despite potent antiretroviral therapy, HIV-associated dementia results in significant morbidity and mortality.
Exercise May Slow Brain Deterioration in Alzheimer Disease
Findings did not differ between aerobic exercise and stretching and toning.
Screening for Cognitive Decline in Primary Care
Although an estimated 82 million people worldwide will be affected by dementia by 2030, research demonstrates that cognitive decline often goes unrecognized in primary care settings.
Migraines Linked to Higher Risk for Dementia, Alzheimer Disease
However, no link seen between migraines and vascular dementia.
Next post in Neurology Information Center
